A prospective study for assessment of cardiovascular risk in polycystic ovarian syndrome
Not Applicable
Recruiting
- Conditions
- Endocrine, nutritional and metabolic disease
- Registration Number
- KCT0000092
- Lead Sponsor
- Ewha Womans University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 350
Inclusion Criteria
1. age: 25-34 years old
2. oligomenorrhea: menstrual cycle>35days, less than 10 menstrual cycle/year
3. Hyperandrogenenmia: total T >65ng/dL, calculated free T >0.86ng/dL
4. normal prolactin level
5. no drugs users( hormone drug, insulin sensitizing drug, weight control drug, antihypertensive drugs) within three months of testing
6. other standards set by steering committee
Exclusion Criteria
1. Hyperprolactinemia
2. Congenital adrenal hyperplasia
3. Cushinng sybdrome
4. Other endocrine disorder which caused hyperandrogenism
5. androgen-secreting tumors
6. drugs users( hormone drug, insulin sensitizing drug, weight control drug, antihypertensive drugs) within three months of testing
7. other standards set by steering committee
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method hypertension;Dyslipidemia;obesity;intermediate marker of CV disease;metabolic syndrome
- Secondary Outcome Measures
Name Time Method impaired glucose tolerance;insulin resistance